Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity

Kana Makino, Natsumi Makigusa, Masahiro Kojima

In response to the U.S.\ Food and Drug Administration's (FDA) Project Optimus, a paradigm shift is underway in the design of early-phase oncology trials. To accelerate drug develop…